Genetic variants of the Nrf2/ARE pathway on the risk of anti-tuberculosis drug-induced liver injury: a systematic review - supplementary material

Table S1. Search strategies and results

Table S2. Quality assessment of the included studies (NOS)

Figure S1. Forest plot of AT-DILI risk associated with rs2001350 polymorphism in NFE2L2 of Nrf2/ARE pathway under different genetic model

Figure S2. Forest plot of AT-DILI risk associated with rs6726395 polymorphism in NFE2L2 of Nrf2/ARE pathway under different genetic model

Figure S3. Forest plot of AT-DILI risk associated with rs2070401 polymorphism in BACH1 of Nrf2/ARE pathway under different genetic model

Figure S4. Forest plot of AT-DILI risk associated with 14 SNPs polymorphism (reported by 2 different studies) in the Nrf2/ARE pathway (dominant model)

Figure S5. Forest plot of AT-DILI risk associated with 14 SNPs polymorphism (reported by 2 different studies) in the Nrf2/ARE pathway (recessive model)

Figure S6. Forest plot of AT-DILI risk associated with 14 SNPs polymorphism (reported by 2 different studies) in the Nrf2/ARE pathway (allele model)

Figure S7. Risk of bias of the included studies.